POLSKA / ENGLISH HOME | SITE MAP | NEWSLETTER | WHO WE ARE PHARMACY ZONE HOSPITAL ZONE SUPPLIER'S ZONE INVESTOR'S ZONE REAL ESTATE JOB CONTACT Home Investor's Zone Letter from the President of the Management Board LETTER FROM THE PRESIDENT OF THE MANAGEMENT BOARD CURRENT REPORTS PERIODIC REPORTS SHAREHOLDING STRUCTURE BASIC CORPORATE DOCUMENTS CORPORATE GOVERNANCE GENERAL MEETINGS PRESS RELEASES / QUESTIONS & ANSWERS CALENDAR CONTACT FARMACOL SA ul. Rapeseed 2 40-541 Katowice phone: 32 208 06 00 e-mail: info@farmacol.com.pl MORE NEWSLETTER If you want to receive information about new products, enter your e-mail address and click OK PROBE Are you a participant of the FarmaProfit program? Yes No Letter from the President of the Management Board Print the page Dear Shareholders! I hereby have the pleasure to present you the Management Board's report on the activities of the Farmacol Capital Group in the past year. 2015 was another good period in the company's 25-year history, although there were many market challenges that focused on falling margins and the progressive change in the pharmaceutical distribution model. In response to changes in the external environment, we continued the implementation of key projects, focusing our activities around: further improvement of the quality of cooperation with the client, development of distribution channels or investments in own brands. The Capital Group recorded an increase in revenues by 10% compared to 2014, i.e. by PLN 548 million. The Capital Group closed 2015 with a net result of PLN 92.3 million, thus confirming the strong financial foundations. In order to create a clear holding structure, taking full advantage of the synergy effect, in which Farmacol SA will mainly conduct holding activities, on March 12, 2016, the Wholesale Center was separated from the Company and transferred along with the employees within the organized part of the enterprise to a subsidiary - Farmacol Logistyka Spółka z oo with its seat in Katowice, in which Farmacol SA holds 100% of shares in the share capital. On behalf of the Management Board, I would like to thank the Shareholders, Partners and Employees for their contribution to the development of the Company so far. At the same time, I hope that the submitted report will be interesting for you and that it will explain the processes taking place in the Company in the past year. Yours sincerely, Barbara Kaszowicz Vice President of the Management Board of Farmacol SA We use cookies to provide services and keep statistics. Using the site without changing your browser settings means that they will be placed on your end device. Remember that you can always change these settings. Details can be found in the Cookies Policy . CONTACT DETAILS FARMACOL SA ul. Rzepakowa 2 40-541 Katowice tel. 32 208 06 00 © FARMACOL SA 2014 Design and implementation: Ideo TELEMARKETING DEPARTMENTS Katowice tel. 801 163 017 Warsaw tel. 801 285 951 Poznan tel. 801 101 083 Gdansk phone: 801 150 032 Rzeszow tel. 801 144 502 Białystok tel. 800 127 042 Kielce tel. 801 137 031 Szczecin tel. 801 234 438 Wroclaw tel. 801 166 006 GENERAL OFFICE farmacol@farmacol.com.pl / tel. 32 20 80 600 OFFICE OF THE MANAGEMENT BOARD officeozarzadu@farmacol.com.pl / tel. 32 20 80 700